Treatment ofAcinetobacterInfections | Zendy

Joel T. Fishbain | Zendy; Anton Y. Peleg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment ofAcinetobacterInfections

Author(s) -

Joel T. Fishbain,

Anton Y. Peleg

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/653120

Subject(s) - acinetobacter baumannii , medicine , intensive care medicine , antimicrobial , acinetobacter , antibiotic resistance , medline , antibiotics , microbiology and biotechnology , pseudomonas aeruginosa , biology , genetics , bacteria , biochemistry

Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited well-controlled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research